What You Should Know
- Optura, an enterprise healthcare platform, has announced a $17.5M Series A funding round led by Salesforce Ventures, bringing its total funding to over $25M.
- The platform introduces ROAI™ (Return on AI Investment), a discipline designed to help healthcare organizations objectively measure the business value and viability of AI initiatives.
- Despite the industry spending over $18B on AI this year, approximately 95% of enterprise GenAI pilots have failed to produce measurable value.
- The platform is currently utilized by major health plans and providers, including Independence Blue Cross and Ardent Health, with more than $2 billion in AI initiatives currently tracked.
- Optura translates leadership priorities into operational AI agents built directly from existing workflows and SOPs, simulating returns before any capital is committed.
Healthcare is currently facing an “AI results problem” rather than an adoption problem. While nearly half of all healthcare investment is now directed toward AI, many organizations find themselves with a “never-ending menu of point solutions” that lack an objective framework for measuring success. Optura is moving to close this accountability gap by providing a platform that ranks use cases against organizational priorities and provides real-time visibility into enterprise impact.
Andy Fanning, Co-Founder and CEO of Optura, noted that as foundational models like Claude for Healthcare enter the market, the cost of “chasing AI hype” without a disciplined approach to ROI has become an existential risk for many organizations.
Solving the “Knowledge Fragmentation” Barrier
One of the primary obstacles to successful AI deployment is the fragmentation of organizational data. Optura’s platform addresses this by mapping existing data into a unified knowledge layer to ground every AI decision in the actual operations of the business.
- Systematic Prioritization: The platform scores use cases based on organizational cost, readiness, and strategic priority.
- Simulation Before Deployment: Leadership can simulate expected returns to determine projected value before a single dollar is spent on deployment.
- Real-Time Dashboards: Once deployed, AI agents are tracked on a unified dashboard that monitors live outcomes against original projections.
Driving Accountability in the C-Suite
The entry of Salesforce Ventures and Echo Health Ventures underscores a market shift toward disciplined AI adoption. Katie Thiry, Managing Director at Salesforce Ventures, stated that Optura helps customers move beyond “AI experimentation” toward delivering measurable business outcomes.
For organizations like Independence Blue Cross, the platform provides a clear answer to whether AI investments are actually improving outcomes for members. With $120M in tracked value already identified at a 700% ROAI™ on in-flight initiatives, the platform is setting a new standard for how healthcare leaders justify and govern their digital transformations.
